Nicosia S - Search Results

1

Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer.

Pal T, Akbari MR, Sun P, Lee JH, Fulp J, Thompson Z, Coppola D, Nicosia S, Sellers TA, McLaughlin J, Risch HA, Rosen B, Shaw P, Schildkraut J, Narod SA. Pal T, et al. Among authors: nicosia s. Br J Cancer. 2012 Nov 6;107(10):1783-90. doi: 10.1038/bjc.2012.452. Epub 2012 Oct 9. Br J Cancer. 2012. PMID: 23047549 Free PMC article.

2

Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer.

Coppola D, Nicosia SV, Doty A, Sellers TA, Lee JH, Fulp J, Thompson Z, Galeb S, McLaughlin J, Narod SA, Schildkraut J, Pal T. Coppola D, et al. Among authors: nicosia sv. Anticancer Res. 2012 Nov;32(11):4963-9. Anticancer Res. 2012. PMID: 23155266 Free PMC article.

3

Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer.

Lee JH, Cragun D, Thompson Z, Coppola D, Nicosia SV, Akbari M, Zhang S, McLaughlin J, Narod S, Schildkraut J, Sellers TA, Pal T. Lee JH, et al. Among authors: nicosia sv. Genet Test Mol Biomarkers. 2014 Apr;18(4):229-35. doi: 10.1089/gtmb.2013.0393. Epub 2014 Mar 4. Genet Test Mol Biomarkers. 2014. PMID: 24592941 Free PMC article.

4

Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer.

Permuth-Wey J, Boulware D, Valkov N, Livingston S, Nicosia S, Lee JH, Sutphen R, Schildkraut J, Narod S, Parker A, Coppola D, Sellers T, Pal T. Permuth-Wey J, et al. Among authors: nicosia s. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):28-34. doi: 10.1158/1055-9965.EPI-08-0713. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19124477 Free PMC article.

5

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R. Pal T, et al. Among authors: nicosia s. Cancer. 2005 Dec 15;104(12):2807-16. doi: 10.1002/cncr.21536. Cancer. 2005. PMID: 16284991 Free article.

6

Cytology of human ovarian surface epithelial brushings.

Nicosia SV, Wilbanks GD, Saunders B, Mayer J, Cardosi RJ, Kruk PA, Cheng J, Bai W, Coppola D, Fiorica J. Nicosia SV, et al. Cancer. 2004 Feb 25;102(1):1-10. doi: 10.1002/cncr.20001. Cancer. 2004. PMID: 14968412 Free article.

7

The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.

Coppola D, Saunders B, Fu L, Mao W, Nicosia SV. Coppola D, et al. Among authors: nicosia sv. Cancer Res. 1999 Jul 1;59(13):3264-70. Cancer Res. 1999. PMID: 10397275

8

Oncogenic pathways implicated in ovarian epithelial cancer.

Nicosia SV, Bai W, Cheng JQ, Coppola D, Kruk PA. Nicosia SV, et al. Hematol Oncol Clin North Am. 2003 Aug;17(4):927-43. doi: 10.1016/s0889-8588(03)00056-x. Hematol Oncol Clin North Am. 2003. PMID: 12959183 Review.

9

Significance of Fas receptor protein expression in epithelial ovarian cancer.

Reed J, Hakam A, Nicosia SV, Coppola D. Reed J, et al. Hum Pathol. 2005 Sep;36(9):971-6. doi: 10.1016/j.humpath.2005.06.015. Hum Pathol. 2005. PMID: 16153459

10

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.

Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ. Yang H, et al. Cancer Res. 2008 Jan 15;68(2):425-33. doi: 10.1158/0008-5472.CAN-07-2488. Cancer Res. 2008. PMID: 18199536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters